Zacks Investment Research
30 Jul 2026, 01:36 UTC · 13w ago
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
Impact · against what's priced in
Bausch Health delivered a significant earnings beat and revenue growth, providing a short-term positive catalyst. However, the impact is tempered by a strong sell rating and a year-to-date price decline of 35%, suggesting the market remains skeptical of the company's long-term trajectory despite the quarterly outperformance.
- BHC+0.30
No priced-in read yet
- In context
The company reported earnings of $1.26 per share and revenues of $2.85 billion, exceeding consensus estimates by 31.25% and 7.62% respectively.
Read from the article alone
